Accelmed Partners Ii Management, LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Website: https://www.accelmed.com/
HQ: FL

Accelmed Partners II Management, LLC is a HealthTech investor. Its core strategy is to identify companies with the potential to become leaders in HealthTech, then develop them through control and growth investments. The team includes Managing Partner Dr. Uri Geiger, General Partner Stephen Rubin, and Chief Medical Officer Dr. Guy Ohad. Portfolio companies include NeuroPace, Click Therapeutics, and Veranex.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

Tag	Says	Does
Stages	Growth	Not enough dated deals
Sectors	Digital health, Medical devices, Life sciences and research tools	Not enough dated deals
Regions	US	Not enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

Fund	Year	Size	Status
Accelmed Partners II L.P.	2020	$400.76M (Form D)	Follow-ons only

03 · People across funds

Uri Geiger
Accelmed Partners II L.P. (Named on Form D)
Camilo Rico, Principal
Accelmed Partners II L.P. (Team)
Daniel Cohen, Venture Partner
Accelmed Partners II L.P. (Team)
Dr. Guy Ohad, M.D., Chief Medical Officer
Accelmed Partners II L.P. (Team)
Dr. Susan Alpert, M.D., Ph.D., Chief Regulatory Officer
Accelmed Partners II L.P. (Team)
Dr. Uri Geiger, Managing Partner
Accelmed Partners II L.P. (Team)
Ilan Ben-Oren, Chief Technology Officer
Accelmed Partners II L.P. (Team)
Maria Forero, Senior Advisor
Accelmed Partners II L.P. (Team)
Stephen Rubin, General Partner
Accelmed Partners II L.P. (Team)

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 25, 2026